How GLP-1s Are Reshaping the Economy and Who's Really Paying for It

How GLP-1s Are Reshaping the Economy and Who's Really Paying for It

July 15, 2026 · 28 min

About this episode

Vivian explores the intersection of weight bias, finances, and the impact of GLP-1 medications on the economy.

Vivian dives into the "thinness economy" and the surprising ways weight bias can affect your finances, career, and earning potential. From GLP-1 medications like Ozempic and Wegovy to workplace discrimination, social media beauty standards, and the booming weight loss industry, this episode explores the uncomfortable intersection of money, health, and appearance. In this episode, you'll learn: 1. How weight bias impacts hiring, salaries, promotions, and long-term wealth, why obesity is a disease rather than a moral failure, and the hidden economic costs of discrimination. 2. The real financial tradeoffs of GLP-1 medications, including who can actually afford them, what insurance does and doesn't cover, and whether these drugs are a financial investment or simply another expensive response to societal pressure. 3. How the "thinness economy" is reshaping entire industries… from grocery stores and restaurants to airlines, fashion, and healthcare, and what these shifts mean for your wallet and the future of consumer spending. Follow the podcast on Instagram and TikTok! Got a financial question you want answered in a future episode? Email us at podcast@yourrichbff.com Learn more about…

More episodes of Networth and Chill with Your Rich BFF

Explore listener stats, chart rankings, contacts and more on the Networth and Chill with Your Rich BFF podcast page.